ScreenerHero
NEUNEUCA S.A.Partial data
GPW · PL · Healthcare · Medical Distribution · neuca.pl
766.00PLN-2.67%Mkt Cap: 901.47M $P/E: 20.56

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Act…

Industry Peers

Medical Distribution
Screen all
MCK
McKesson Corporation
$99.53BUSDP/E 22.9
COR
CoreSite Realty Corporation
$60.51BUSDP/E 23.5
CAH
Cardinal Health, Inc.
$54.62BUSDP/E 32.4
HSIC
Henry Schein, Inc.
$10.17BUSDP/E 26.0
GALE
Galenica AG
$4.70BUSDP/E 25.6
SELEC
Selcuk Ecza Deposu Ticaret ve Sanayi A.S.
$4.22BUSDP/E 79.3
AMP
Amplifon S.p.A.
$3.42BUSDP/E 38.2
ASKER
Asker Healthcare Group AB
$2.81BUSDP/E 43.1
UPR
Uniphar plc
$1.17BUSDP/E 20.7
ARJO-B
Arjo AB (publ)
$747.71MUSDP/E 20.2
M12
M1 Kliniken AG
$371.48MUSDP/E 15.3
ILM1
Medios AG
$301.63MUSDP/E 23.7
BLC
Bastide Le Confort Medical SA
$180.35MUSDP/E 18.0
MLFMV
Farminveste, S.G.P.S., S.A.
$115.23MUSD
ACH
Aluminum Corporation of China Limited
$101.51MUSD
NAVA
Navamedic ASA
$34.63MUSD
RMAH
Farmaceutica REMEDIA S.A.
$18.14MUSDP/E 11.1
ALEMG
Euromedis Groupe
$15.46MUSD
WGRX
Wellgistics Health Inc. Common Stock
$8.85MUSD
MEDS
Trxade Group, Inc.
$4.38MUSD

Key Statistics

Company
Market Cap901.47M $
Enterprise Value1.07B $
Revenue (TTM)3.50B $
Gross Profit394.67M $
Net Income (TTM)39.40M $
Revenue/Share770.32 USD
Last Price766.00 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5.0K
CountryPL
SectorHealthcare
IndustryMedical Distribution
ISINPLTRFRM00018
Valuation
P/E (Trailing)20.56
P/E (Forward)13.86
PEG—
EV/EBITDA12.16
EV/Revenue0.30
P/S0.25
P/B2.97
EPS (TTM)38.25
EPS (Forward)54.70
52W Range
645.0057% of range857.00
52W High857.00 PLN
52W Low645.00 PLN
Profitability
Gross Margin11.42%
Oper. Margin2.72%
EBITDA Margin2.50%
Profit Margin1.14%
ROE14.71%
ROA2.49%
Growth
Revenue Growth5.70%
Earnings Growth39.70%
Cash Flow & Leverage
Operating CF139.01M $
CapEx (TTM)31.63M $
FCF Margin1.92%
FCF Yield7.44%
Net Debt156.95M $
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.47
Current Ratio0.90
Quick Ratio0.49
Book Value/Sh255.57 PLN
Cash/Share41.12 PLN
Dividends
Fwd Div Rate17.80 PLN
Trail. Div Rate17.80 PLN
Div. Yield2.37%
5Y Avg Yield1.78%
Payout Ratio41.83%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)922.64 PLN
Upside (mean)+20.4%
Target Range830.00 PLN – 1002.20 PLN
PLN830.00+20.4% to meanPLN1002.20
# Analysts5
Ownership
Shares Out.4.52M
Float1.63M
Insiders60.58%
Institutions9.97%
Technical
SMA 50735.02 (+4.2%)
SMA 200755.89 (+1.3%)
Beta0.46
S&P 52W Chg19.97%
Avg Vol (30d)2.29K
Avg Vol (10d)2.41K
Technical Indicators
RSI (14)71.1
MACD10.8352
MACD Signal2.8686
MACD Hist.+7.9666
BB Upper774.90 PLN
BB Middle726.65 PLN
BB Lower678.40 PLN
BB Width13.28%
ATR (14)20.12 PLN
Vol Ratio (20d)0.33x